Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0LP2K
|
|||
Former ID |
DNC013104
|
|||
Drug Name |
3-demethoxy-3-D-mannopyranosylaminothiocolchicine
|
|||
Synonyms |
CHEMBL214305
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C27H34N2O9S
|
|||
Canonical SMILES |
CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)NC4C(C(C(C(O4)CO)O)O)O
|
|||
InChI |
1S/C27H34N2O9S/c1-12(31)28-16-7-5-13-9-17(29-27-24(35)23(34)22(33)19(11-30)38-27)25(36-2)26(37-3)21(13)14-6-8-20(39-4)18(32)10-15(14)16/h6,8-10,16,19,22-24,27,29-30,33-35H,5,7,11H2,1-4H3,(H,28,31)/t16-,19+,22+,23-,24-,27+/m0/s1
|
|||
InChIKey |
FPOIHQLRIKBTGP-LMOMQKJLSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | GABA(A) receptor alpha-1 (GABRA1) | Target Info | Inhibitor | [1] |
GABA(A) receptor beta-2 (GABRB2) | Target Info | Inhibitor | [1] | |
GABA(A) receptor gamma-2 (GABRG2) | Target Info | Inhibitor | [1] | |
Gamma-aminobutyric acid receptor (GAR) | Target Info | Inhibitor | [1] | |
Glycine receptor (GlyR) | Target Info | Inhibitor | [1] | |
Strychnine-binding glycine receptor (GLRA1) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Retrograde endocannabinoid signaling | ||||
GABAergic synapse | ||||
Morphine addiction | ||||
Nicotine addiction | ||||
Serotonergic synapse | ||||
Reactome | Ligand-gated ion channel transport | |||
GABA A receptor activation | ||||
WikiPathways | SIDS Susceptibility Pathways | |||
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | ||||
Iron uptake and transport |
References | Top | |||
---|---|---|---|---|
REF 1 | 3-demethoxy-3-glycosylaminothiocolchicines: Synthesis of a new class of putative muscle relaxant compounds. J Med Chem. 2006 Sep 7;49(18):5571-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.